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a b s t r a c t
The Hepatitis B virus Precore protein, present in the secretory pathway as the HBeAg precursor, can
associate in the cytoplasm with the Core protein to form heterocapsids, likely to favor viral persistence.
Core and Precore proteins share their primary sequence except for ten additional aminoacids at the N-
terminus of Precore. To address the role of this propeptide sequence in the formation of Precore
heterocapsids, we designed a Precore mutant in which the two propeptide tryptophans are replaced by
glycines. This mutant retains the properties of the wild-type Precore, notably cell trafﬁcking and ability
to interact with Core. However, it is not incorporated into heterocapsids and forms stable dimers distinct
from the labile HBe dimers and the presumably Core-like dimers assembled into heterocapsids. Our data
highlights the essential role of Precore's propeptide in switching between different conformations for
different functions and pinpoint the propeptide Tryptophan residues as central in these properties.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The hepatitis B virus is an enveloped DNA virus with an
icosahedral capsid composed of a single protein, the Core protein
(Summers et al., 1975). The capsid encloses the viral DNA,
covalently linked to the viral polymerase (Bartenschlager and
Schaller, 1988). The Core protein (183 residues, Fig. 1A) is encoded
by the same PreC/C open reading frame as the Precore protein
precursor. They are translated from different in-frame AUG codons
and consequently share the Core primary sequence, with an
extended amino-terminal region of 29 amino acids (aa) for the
Precore protein precursor. By convention the ﬁrst residues of Core
and Precore precursor are numbered (þ1) and (29), respectively
(Fig. 1A). Translation from the Precore AUG leads to the Precore
protein precursor (P25), which is co-translationally directed to the
secretory pathway by a 19-amino acid signal peptide. The latter is
cleaved during translocation of the nascent chain into the lumen
of the endoplasmic reticulum (ER), leading to the Precore mature
protein (22 kDa) (Ou et al., 1986). Thus, Precore differs from Core
by two features: (i) an extended 10 aminoacids N-terminal
sequence and (ii) a different intracellular localization since it is
present in the secretory pathway while Core is a cytoplasmic
protein. However, about 15% of Precore is released back to the
cytosol by hijacking the ER-associated degradation pathway
(Duriez et al., 2008; Guidotti et al., 1996; Messageot et al., 2003;
Ou et al., 1989), while the majority of the Precore molecules are
processed by removal of the C-terminal 29 residues to give rise to
the secreted HBe (Messageot et al., 2003).
One important feature of HBV is its capacity to maintain a viral
persistence. To achieve this goal, HBV has developed different
strategies including immune escape, a process in which HBe
appears as a key viral protein (Dandri and Locarnini, 2012;
Milich et al., 1998). However, another precore gene product could
be involved in a different mechanism favouring persistent infec-
tion. Indeed, several data indicate that the Precore protein present
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in the cytoplasm regulates viral multiplication negatively. In this
regard, HBV replication was reduced strongly in HBV transgenic
mice crossed with animals overexpressing the Precore protein
(Guidotti et al., 1996). Moreover, mutations leading to an abolition
of Precore gene expression resulted in a signiﬁcant increase of HBV
replication in transfected cells (Lamberts et al., 1993; Scaglioni et
al., 1997a). Finally, when Precore deleted of its signal peptide was
over-expressed in cells, Core–Precore immature capsids were
observed suggesting that the formation of unstable nucleocapsids
containing cytosolic Precore would be a means to reduce viral
secretion (Scaglioni et al., 1997b).
In this paper, we focused our attention on the role of the N-
terminal 10 aa sequence of Precore, here referred to as the
propeptide sequence, that is almost identical in all orthohepadna-
viruses (Revill et al., 2010). Recent data relative to HBe, the
processed and secreted form of Precore, have attributed two
functions to this unique region. First, as it contains a Toll/IL-1
receptor motif it could allow HBe to interfere with the innate
immune system (Lang et al., 2011). Second, crystallographic
studies of HBe expressed in Escherichia coli have revealed that
the propeptide induces a spectacular quaternary structure switch
in HBe relative to Core (DiMattia et al., 2013). Indeed, whereas the
tertiary structures of the two proteins are very similar and they
both form dimers (Watts et al., 2011), the second subunit is rotated
by 1401 in the HBe dimer relative to the Core dimer in the capsid
structure. This radical change is directly caused by the propeptide
that (i) shields atoms that would be engaged in the Core dimer
interface, thus preventing Core-like dimerization (Fig. 1B) (ii) is
itself largely buried in the HBe dimer interface (Fig. 1C). Central to
these features are (i) an intramolecular disulﬁde bond between
Cys(7) and Cys(61) (Nassal and Rieger, 1993) that tethers the
propeptide to this part of the Core fold (Fig. 1B), and (ii) the (4)-
Trp-Leu-Trp(2) tripeptide that provides a hydrophobic bulge
bridging the HBe dimer interface (Fig. 1B and C). In contrast, in
Core dimers the two Cys(61) lie opposite each other across the
dimer interface and can form an intermolecular disulﬁde bond
connecting the two monomers. This led us to study the role of
the (4)-Trp-Leu-Trp(2) tripeptide in Precore in a relevant
Fig. 1. Proteins encoded by the PreC/C open reading frame and propeptide location in the HBe structure. (A) Schematics of PreC/C gene products. Cysteines 7 and 61
that form an intramolecular disulﬁde bond in HBe are indicated. (B) Surface representation of a single HBe molecule with its propeptide in stick representation. Atoms that
would be buried in a Core dimer interface are colored pink. Note that tethering of Cys(7) through its disulﬁde bond leads to the propeptide covering part of this pink
surface. (C) The HBe dimer. Left, surface representation of the dimer with the interacting surfaces colored magenta and blue. Note that the interface is much smaller than in
the Core dimer, in accordance with its lower stability. Right, the tripeptide (4)WLW(2) provides a key hydrophobic bulge at the periphery of the HBe dimer interface. For
clarity, the white molecule is hidden except for the propeptide that is in stick representation as in B/. The dimer has been rotated to view the propeptide from the opposite
side with respect to (B).
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experimental system. To this end, we developed a new replicating
HBV cell line mimicking natural infection conditions and we
designed a mutated form of Precore in which the two Trp residues
of the hydrophobic tripeptide were replaced by two Gly residues.
In addition, plasmids encoding an HA-tagged Precore were con-
structed to allow us to distinguish Core and Precore proteins in the
absence of speciﬁc antibodies. We demonstrated that the Precore
mutant is biosynthesized, secreted and retrotransported to the
cytosol as the wild-type protein, excluding a role of the 2 Trp
residues in these mechanisms. Interestingly, the Precore mutant
still forms dimers, that are surprisingly more stable than the wild
type, and is still able to interact in vitro with the Core protein but
cannot form heterocapsids in our HBV replicating cell lines. Taken
together, our results show that the replacement of the two Trp
residues of the propeptide sequence by glycine residues disrupts
the formation of cytosolic Core–Precore heterocapsids even
though the mutant Precore forms stable dimers whether in a
reducing or an oxidizing environment. Thus the two Trp side
chains that contribute to presenting the propeptide in such a way
that formation of the Cys(7)-Cys(61) and hence an HBe-like
dimer is facilitated in an oxydizing environment (DiMattia et al.,
2013) are also necessary for Precore to form a Core-like dimer in
the reducing environment of the cytosol. These observations hint
at a further, previously unsuspected dimerization mode of Precore
besides the Core-like and HBe dimers.
Results
The Trp residues of the propeptide sequence are not required for the
retrotransport of Precore from the ER to the cytoplasm
To obtain new insights into the role of the propeptide sequence
of the cytoplasmic form of Precore, we focused our studies on the
hydrophobic residues present in this sequence. To achieve this
goal, we replaced the two Trp residues at (4) and (2) positions
by Gly ones. In a ﬁrst step we examined whether the mutations
modiﬁed the intracellular localization of Precore. A cell system
highly transfectable is required to detect the cytosolic part of
Precore, as it represents around 10% of the total expressed protein.
To this purpose, HEK-293 T cells were transfected with plasmids
encoding the wild-type (Precore) or the mutated protein (Precor-
eWG). Cells were processed for immunoﬂuorescence analyses with
antibodies directed against either the Golgi marker GM130 or the
Precore protein (the anti-Core antibody detected both Precore and
Core proteins). As shown in Fig. 2A, both Precore and PrecoreWG
proteins were readily detected by the polyclonal anti-Core anti-
body and were present mainly in the secretory pathway as
demonstrated by their colocalization with the Golgi compartment.
Interestingly the localization of the HA-tagged Precore protein was
identical (Fig. 2A), conﬁrming that it could be used to distinguish
Precore from Core in the following experiments. To go further, it is
of importance to examine whether the Trp mutations affect the
retrotransport of Precore from the ER to the cytoplasm. To this end,
a cytosolic fractionation was performed on HEK-293 T cells trans-
fected with plasmids encoding Precore, HA-Precore or HA-
PrecoreWG. The cytosolic and non-cytosolic fractions were ana-
lyzed by Western blot (Fig. 2B). As a control, the blot was probed
with an antibody directed against the luminal ER protein PDI. The
absence of this protein in the cytosolic extracts allowed us to
exclude that proteins from the ER had contaminated the cytosolic
fractions. As expected, Precore was detected in the cytosolic and
non cytosolic fractions with the polyclonal antibody anti-Core.
Similarly, HA-Precore and HA-PrecoreWG proteins were detected
in both fractions, demonstrating that neither the HA-tag nor the
Trp replacements impair the retrotransport of Precore (Fig. 2B,
lanes 6–8). The presence of BiP protein in cytosolic fractions
(Fig. 2B, lanes 6–8) was expected as Precore retrotransport targets
a subset of BiP protein to the cytoplasm (Duriez et al., 2008). We
next investigated whether the mutation of the Trp residues could
modify Precore secretion. To this purpose, the amounts of HBe
secreted in the media of HEK-293 T cells expressing the mutated or
the wild-type protein were quantiﬁed. As shown in Fig. 2C, no
signiﬁcant difference in the levels of secreted HBe was observed. In
conclusion, these results demonstrate that the presence of an N-
terminal HA-tag or the replacement of Trp residues by Gly do not
affect Precore localization, HBe secretion or Precore retrotransport
from the ER to the cytoplasm.
The tryptophan residues in the propeptide sequence are not critical
for Precore interaction with Core
We then asked whether the Trp residues were essential for the
Core–Precore interaction described previously (Scaglioni et al.,
1997b). HEK-293 T cells were co-transfected transiently with Core
and HA-Precore, HA-PrecoreWG or the irrelevant SEAP-HA protein
expression vectors. Crude extracts were prepared and immuno-
precipitations directed against the HA epitope were performed.
Crude extracts and IP products were analyzed by Western blot
with a polyclonal antibody directed against the Core protein. The
Core protein (arrow) as well as the HA-Precore wild-type and
mutant proteins are detected in crude extracts by the polyclonal
antibody anti-Core (Fig. 3, lanes 2–5). As shown in Fig. 3, lanes
7 and 8, the Core protein (arrow) was co-immunoprecipitated with
HA-Precore or HA-PrecoreWG but not with SEAP-HA (lane 9),
demonstrating a speciﬁc interaction between Core and HA-Precore
which is not dependent of the presence of the 2 Trp residues. We
also investigated if the mutations of Trp residues on the propep-
tide sequence disrupted the interaction of Precore with its cellular
partner gC1qR (Laine et al., 2003). This was not the case as gC1qR
was co-immunoprecipitated with the wild-type and mutated
Precore proteins (Fig. 3, lanes 7 and 8). These data suggest that
mutations of the two hydrophobic Trp residues in the propeptide
sequence do not modify drastically the tertiary structure of the
Precore protein and indicate that the two Trp are not critical for its
interactions with Core or gC1qR.
Replacement of the 2 Trp residues in the propeptide sequence
stabilizes Precore dimers
The fact that HA-Precore as HA-PrecoreWG interacts with
the Core protein strongly suggests that both proteins can form
heterocapsids with Core in the reducing environment of the
cytosol. However, different data obtained with a recombinant
HBe indicate that the propeptide sequence plays a role in the
stability of the HBe dimers, allowing incorporation into capsids in
reducing conditions (presumably as Core-like dimers) but indu-
cing the alternate HBe dimer in oxidizing conditions (DiMattia et
al., 2013; Watts et al., 2011). Thus, we next investigated whether
the wild-type and mutated Precore could dimerize and if these
dimers had an identical stability. HA-Precore and HA-PrecoreWG
were extracted from HEK-293 T in the presence or absence of
dithiothreitol (DTT) and subjected to SDS-PAGE. Core-like disul-
ﬁde-linked dimers will migrate as dimers if kept in oxidizing
conditions but dissociate into apparent monomers in reducing
conditions, while non-disulﬁde-crosslinked dimers will dissociate
in both conditions. Interestingly we observed that the two proteins
did not have the same behavior in oxidizing or reducing condi-
tions. Oxidized HA-Precore protein migrated under the two forms,
monomeric and dimeric and mostly as a monomer when treated
with the reducing agent DTT prior to electrophoresis (Fig. 4, lanes
1 and 2). This behavior is very similar to that observed for Core
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Fig. 2. PrecoreWG mutant is biosynthesized and secreted as the wild-type protein. HEK-293 T cells were transfected with p-Precore, p-PrecoreWG or p-HA-Precore.
(A) Immunostaining experiments were performed using an anti-Core antibody to detect Precore (red for Precore and PrecoreWG, green for HA-Precore) and GM130 (green for
Precore and PrecoreWG, red for HA-Precore). Nuclei were stained with DAPI (blue). A merge of the three stainings was realized. (B) After cytosolic fractionation, cytosolic and non-
cytosolic extracts were subjected to a SDS-PAGE. Blots were probed with the antibodies indicated on the right. The band corresponding to the Precore form is marked by an arrow (lane
2), whereas Core, which is slightly expressed by this vector, is indicated with an asterisk (previously characterized in (Duriez et al., 2008)). The two bands corresponding to HA-Precore
are indicated (lane 8). The upper band is not always present in our experiments and could be the result of post-translational modiﬁcation (Duriez et al. 2008). (C) Supernatants of non
transfected cells (NT) or transfected cells (p-HA-Precore and p-HA-PrecoreWG) were analyzed by ELISA to quantify HBe. Experiments were repeated at least three times.
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(not shown) and indicates that a portion of Precore molecules
forms a dimer with the formation of an intermolecular disulﬁde
bond, presumably a Core-like dimer. Another portion of Precore
may form HBe-like dimers with an intramolecular bond between
the Cys(7) and the Cys(61) as shown for recombinant HBe
molecules (Watts et al., 2011). However, the present experiment
does not allows detection of this intramolecular bond since HBe
dimers are less stable than Core dimers (Watts et al., 2011), and
HBe-like Precore dimers will dissociate and migrate as monomers
in SDS-PAGE, regardless of oxidation state. At any rate, any HBe-
like dimers would be expected to be destabilized in the mutant
Precore since the two removed tryptophan side chains are promi-
nently involved in the HBe dimer interface (Fig. 1B and C).
Surprisingly, HA-PrecoreWG migrated almost entirely as a dimer
in all cases (Fig.4, lanes 3 and 4). Thus PrecoreWG is more stable as
a dimer than Core-like or HBe-like dimers. Since we observe no
detectable difference between oxidizing and reducing conditions,
we cannot assess whether this PrecoreWG dimer involves a
disulﬁde crosslink. Taken together, our results show that Precor-
eWG predominantly assumes a dimeric conformation distinct
from both the previously reported Core-like and HBe-like dimers
(DiMattia et al., 2013), suggesting that the Glycine–rich peptide in
the mutant favours a new conformational state.
New cell lines allowing infection-like expression of Core and Precore
show that the replacement of the two propeptide Trp residues by
glycines disrupts the formation of Core–Precore heterocapsids
We then decided to analyze the role of the two Trp residues
of the propeptide sequence in HBV cell cycle. To this end, we
established hepatoma HuH-7 cell lines that replicate an HBV
genome defective in Precore synthesis, p-HBV(precore_) in which
HA-tagged wild-type or mutated Precore proteins were provided
in trans. HuH-7 cells carrying HBV(p25) genome and doxycycline
inducible HA-Precore or HA-PrecoreWG vectors were selected as
described in material and methods. The HBV(p25) genome
delivered in HuH-7 is expressed under the control of endogenous
viral regulatory sequences and carries a stop mutation in place of
the 2 Trp codon of Precore (this precore gene mutation naturally
occurs in HBV patients).
In order to assess the expression of viral proteins expression in
these new cell lines, a total protein extract was performed and
proteins analyzed by western blot (Fig. 5A). Detection of PDI
served as a control of total protein extraction (Fig. 5A, panel
PDI). As expected the HBV replicating cell lines expressed Core
(Fig. 5A, panel Core) as well as HA-Precore or HA-PrecoreWG
proteins (Fig. 5A, panels Core and HA). Interestingly, as observed in
natural infection, Core expression was much higher than Precore
expression in the HBV replicating cell lines when both proteins
were detected with the polyclonal anti-Core antibodies (Fig. 5A,
panel Core). As previous reports indicated that Precore reduces the
viral secretion, we next asked whether the WG Precore mutant
inﬂuenced viral secretion. To this end, HBV particles from cell
supernatants were puriﬁed using a 30% sucrose cushion and the
presence of Core and Middle envelope (M) proteins probed by
Western blot. The presence of the M envelope protein should
reﬂect nucleocapsid containing particles (infectious virions) and
subviral empty particles, a hallmark of hepadnavirus infection,
whereas Core detection is only due to the presence of nucleocap-
sid containing particles. As a control, a coomassie staining was
performed to ensure that the same amounts of proteins were
loaded (data not shown). As shown on Fig. 5B, HBV M envelope
proteins were detected in similar amounts in HuH-7 cell lines
expressing the HBV(p25) genome alone or in combination with
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HA-Precore or HA-PrecoreWG proteins. As expected we observed a
signiﬁcant reduction of Core detection in presence of the Precore
protein (Fig. 5B, quantiﬁcation of three independent experiments),
conﬁrming that Precore protein induces a reduction of infectious
virions as already described by Scaglioni et al. (1997b). Interest-
ingly this reduction was not observed in presence of PrecoreWG,
meaning that the replacement of Trp residues abolished Precore
effect on viral secretion. In a second step, intracellular nucleo-
capsids were extracted and analyzed by Western blot in non
denaturating conditions (Fig. 5C). The amounts of intracellular
nucleocapsids were appreciably similar in HuH-7 cell lines expres-
sing the HBV(p25) genome alone or together with HA-Precore
or HA-PrecoreWG proteins. This suggests that the expression of
Precore (wild-type or mutated) does not quantitatively affect the
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Fig. 5. Trp residues from Precore are not required for intracellular and extracellular nucleocapsid detection. HBV-expressing cell lines containing the hygromycin B
resistant plasmid p-HBV(precore-) and either pI-HA-Precore or pI-HA-PrecoreWG plasmids were selected as described in material and methods. (A) Cells were lysed in
Laemmli buffer and extracts were subjected to electrophoresis on a 12.5% polyacrylamide-SDS gel. Blots were probed with antibodies indicated on the right. The bands
corresponding to Core and HA-Precore proteins are indicated. Experiments were repeated three times with similar results. (B) Extracellular media from cells were
concentrated then centrifuged in a 30% sucrose cushion. The resulting pellets were resuspended in Laemmli buffer and subjected to a 12% SDS PAGE. Viral proteins were
detected by western blotting with antibodies indicated on the right. The rabbit anti-HBs antibody directed against the preS2 HBV envelope protein allowed mainly the
detection of the M envelop protein (glycosylated or not). Quantiﬁcations were performed with three independent experiments. * Denotes signiﬁcant difference (p¼0,0274,
unpaired t-test). (C) NP40 extraction was performed as described in material and methods. Extracts were loaded on a 1.2% agarose gel. After migration in non-denaturing
conditions proteins and nucleocapsids were transferred onto a nylon membrane. Western blotting analysis was performed with an antibody directed against Core to reveal
the presence of the intracellular capsid. Three independent experiments showed no signiﬁcant variation between Precore and PrecoreWG.
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global level of intracellular capsids. This result is consistent with
the hypothesis of Scaglioni and co-workers, who proposed that
P22 could interfere with the assembly of viral nucleocapsids and
participate to the formation of hybrid nucleocapsids devoid of
pregenomic viral RNA.
To go further, we determined if the wild-type and mutated
Precore proteins were present in the intracellular nucleocapsids.
After cell lysis, intracellular nucleocapsids were puriﬁed through an
ultracentrifugation on a 30% sucrose cushion, loaded onto a SDS-
PAGE and analyzed by western blot. In addition, total protein extracts
were performed to ensure that HA-Precore and HA-PrecoreWG were
expressed at similar levels (Fig. 6, lanes 1 and 2). Interestingly,
analysis of puriﬁed intracellular nucleocapsids from HA-Precore and
HA-PrecoreWG HBV cell lines revealed a drastic difference. Indeed,
HA-Precore was observed in puriﬁed intracellular nucleocapsids
altogether with Core protein (Fig. 6, lane 4), in agreement with the
data reported previously (Scaglioni et al., 1997b). On the opposite,
HA-PrecoreWG was absent from these structures (Fig. 6, lane 5),
although it was expressed in the same amount as the wild-type
Precore. Overall, these results demonstrate that the replacement of
the two Trp residues of the propeptide sequence by glycine inhibits
the formation of Core–Precore heterocapsids.
Discussion
In this report, we provide a novel molecular insight for the for-
mation of Core–Precore heterocapsids. We show that two hydro-
phobic Trp residues in the propeptide sequence of Precore are
essential for the formation of these heterocapsids. Importantly, it
appears that the replacement of the two Trp residues by Glycines
does not impair Core–Precore interaction but prevents formation
of a Core-like dimeric structure.
The role of the cytosolic form of Precore in the viral life cycle
is still not totally understood. Years ago, several reports using surro-
gate HBV expression systems have showed that Precore down regu-
lates the level of HBV replication (Buckwold et al., 1996; Guidotti et
al., 1996; Lamberts et al., 1993), most likely by the association of
Precore and Core proteins in capsids devoid of pregenomic RNA
(Scaglioni et al., 1997b). To better deﬁne the role of Precore in this
mechanism, we developed a new HBV expression model using a
vector, which replicates as an extrachromosome episome in human
cells, mimicking the viral cccDNA form. Moreover the model allowed
us to detect speciﬁcally Precore with a ratio of Precore to Core
expression similar to the natural infection (less Precore produced
than Core). Thus, this experimental system is very relevant for our
studies on the ability of Precore and PrecoreWG to form hetero-
capsids. Using this relevant experimental system, we conﬁrmed that
Precore and Core proteins can form heterocapsids, as previously
shown (Scaglioni et al., 1997b). Moreover we observe a signiﬁcant
reduction of viral secretion when wild-type Precore assembles with
Core in nucleocapsids. In previous studies Precore was mostly over
expressed without its signal peptide sequence and consequently only
present in the cytoplasm. In our experimental system Precore is
expressed at a relatively low level and is present both in the secretory
pathway and the cytoplasm, thus our data show that the presence of
heterocapsids is not dependent on the overabundance of Precore in
the cytoplasm. According to Scaglioni et al. such an interactionwould
lead to the formation of immature capsids, which are not competent
for replication and consequently cannot be enveloped and secreted.
We sought to shed light on this and other functions of Precore
by mutating the 10-residue Precore propeptide sequence. It was
suggested, years ago, that the Cys(7) and the two Trp residues
(4) and (2) of the propeptide sequence are required to prevent
HBeAg assembly into core-like structures (Wasenauer et al., 1992).
Moreover, recent crystallographic studies of HBe expressed in
E. coli have shown that the formation of the intramolecular
disulﬁde bond between Cys(7) and Cys(61) locks the propeptide
into place, stabilizing Gly(5)-Trp(4)-Leu(3)-Trp(2)-Gly
(1) into a hydrophobic bulge that comes into close contact with
the central part of the protein (Fig. 1B). Consequently, Core-like
dimers cannot be formed but a radically altered mode of dimer-
ization of HBe, relative to Core, occurs which cannot assemble in
capsids (DiMattia et al., 2013). However, in a reducing environ-
ment, the intramolecular disulﬁde bridge is disrupted, and HBe
dimers are able to form capsids, indicating a Core-like mode of
association. If we assume that Precore tertiary structure is close to
that of HBe, we believe that in the cytosol, a reducing environ-
ment, Precore could homodimerize in a Core-like dimer conforma-
tion, allowing the formation of heterocapsids. The two Trp
residues (4) and (2) are central in the oxidized intramolecular
disulﬁde state of HBe both in preventing Core-like dimer forma-
tion (Fig. 1B) and stabilizing the alternate HBe dimer (Fig. 1C) that
is presumably the secreted form. What could be the speciﬁc role of
these Trp residues in the cytosolic fraction of Precore? Surpris-
ingly, the rather drastic change of mutating both Trp residues to
glycines produced a rather mild phenotype in our experimental
system. The PrecoreWG mutant was still expressed, processed and
located as the wild type. The secreted fraction and the retro-
transported fraction were detected in the same quantities as the
wild type and the latter cytosolic PrecoreWG fraction still inter-
acted with Core. It is all the more striking that PrecoreWG has
speciﬁcally lost the ability to be associated with the nucleocapsids.
Furthermore, PrecoreWG formed a very stable dimer indepen-
dently of oxidation conditions. This suggests that the PrecoreWG
dimer is distinct from both the disulﬁde-linked Core-like dimer
and the weaker HBe dimer (DiMattia et al., 2013; Watts et al.,
2011). Since PrecoreWG behaved otherwise identically with Pre-
core, it is tempting to speculate that this mutant has trapped a
previously unsuspected minor Precore conformation. At any rate,
our results suggest a particular role of the two aromatic residues in
the formation of heterocapsids. Thus, the same residues that
prevent a Core-like dimer formation under oxidizing conditions
for the secreted HBe promote it under reducing conditions for the
retro-transported Precore.
PDI
Core
Total 
protein Nucleocapsid
75
50
25
20
kDa
1      2      3       4       5      6
pI-HA-Precore
pI-HA-PrecoreWG
p-HBV(Precore-)+  +  +
+  -  -
-  +  -
HA-Precore
Core
+  +  +
+  -  -
-  +  -
Fig. 6. Trp residues are essential for Precore association with nucleocapsids.
HBV-expressing cell lines containing the p-HBV(precore_) plasmid and pI-HA-
Precore or pI-HA-PrecoreWG were selected as described in Fig. 4. NP40 extraction
was performed as described in material and methods. Extracts were centrifuged for
2 h at 50,000 rpm through a 30% sucrose cushion. Total protein extracts (Total
protein) and resuspended pellets (Nucleocapsid) were subjected to a 12% SDS-
PAGE. A western blotting assay was performed with antibodies indicated on the
right. PDI was detected as a control. Presence of HA-Precore and Core proteins are
indicated. Experiments were repeated three times with similar results.
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Viruses with a compact genome usually optimize its use by
having the same sequences serve several functions. One strategy
for this is coding alternate polypeptide lengths, as in the HIV
reverse transcriptase P66/P51 heterodimer where P51 displays a
very different conformation despite being only a shorter form of
P66 (Kohlstaedt et al., 1992). Another common strategy is to
have the same polypeptide chain that serves different functions
in different contexts, as in the HBV Core, which is known or
suspected to have gene expression tuning functions in its dimeric
form in addition to its primary role in virion formation. Central to
this switch of Core is the role of allostery in HBV capsid assembly
(Alexander et al., 2013; Packianathan et al., 2010). It is noteworthy
that the crystal structure of the pre-assembly conformation of the
Core dimer was obtained with the Y132A mutant (Packianathan et
al., 2010), that shows two important similarities with the Precor-
eWG mutant. First, Y132 is an aromatic residue at the periphery of
an important (interdimer) interface in the capsid, in a similar way
to W(4) and W(2) for the HBe dimer interface (Fig. 1C).
Second, mutating the Y132 side chain not only weakens the
interdimer interface to which it contributes but also leads to
long-distance remodeling of the Core dimer interface. In such a
plastic protein as the Core fold, a similar effect may explain in part
the alternate dimer of PrecoreWG.
HBV is an extreme example with respect to genome compac-
tion. We show here that the single PreC/C open reading frame may
code for even more functions than previously suspected. Particu-
larly the Precore protein's cytosolic fraction may have different
dimeric conformations that may serve different functions in HBV
replication.
Materials and methods
DNA constructs
Plasmid pCEP4m was previously described (Sitterlin et al., 2000).
Plasmid p-Seap-HA (formerly pCEP4mSeap-HA) was previously
described (Duriez et al., 2008). Plasmids p-Core and p-Precore derive
from pCEP4m and allow the expression of Core and Precore genes
under control of the cytomegalovirus promoter, respectively (Duriez
et al., 2008). Plasmid p-PrecoreWG was generated by site-directed
mutagenesis on p-Precore (Trp codons at position 4 and 2 were
replaced by two Gly codons). Plasmid p-HA-Precore allows the
expression of a Precore protein fused to a HA-tag (ASYPYDVPDYAPG)
at its N-terminus end (HA-Precore). This construct was obtained by
inserting a HA-tag coding sequence downstream of the sequence
coding for the signal peptide of the Precore P25 precursor. Thus, after
cleavage of the 19-residues signal peptide, the HA-tag will be present
at the N-terminus of the mature Precore. Plasmid p-HA-PrecoreWG
was generated by site-directed mutagenesis on p-HA-Precore (Trp
codons at position 4 and 2 were replaced by two Gly codons).
It allows the expression of a mutated Precore (HA-PrecoreWG).
Plasmid pI-HA-Precore allows expression of HA-Precore under the
control of an inducible promoter. The CMV inducible promoter
containing tetracycline operator sequences from the pcDNA™4/TO
(Life technologies) was ampliﬁed and inserted at the SalI-HindIII site
of p-HA-Precore, in place of the CMV promoter. The pI-HA-Precor-
eWG, in which the 4 and 2 Trp codons were replaced by two Gly
codons, was generated by site-directed mutagenesis on pI-HA-
Precore. Plasmid p-HBV(precore_) carries a hygromycin B resistance
gene and contains a 1.2-HBV genome unit-length from nucleotides
1402 to 3182 and 1 to 1986 (genotype D, subtype ayw, Gen-
bank♯v01460 (Galibert et al., 1979)) with a mutation in the precore
gene at nucleotide 1896 leading to a stop codon in the propeptide
sequence (TGG to TAG). As the CMV promoter has been deleted from
the pCEP4m vector, HBV RNA transcripts are expressed under the
control of endogenous viral regulatory sequences.
HEK-293T cells transfections
HEK-293 T cells were grown in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% of heat-inactivated fetal calf
serum and 100 units/ml of penicillin and streptomycin. HEK-
293 T cells were transfected with 10 mg of total DNA for 5106
cells using the calcium phosphate procedure as previously
described (Laine et al., 2003).
HBV cell line selection
A HuH-7 stable cell line that constitutively expressed the Tet
repressor was established (HuH-7 Tet Rep). HuH-7 cells were
transfected with the pcDNA6/TR (Life technologies) and selected
with blasticidin (5 mg/ml) to isolate a single stable cell line
expressing the Tet repressor protein. The resulting HuH-7 Tet
Rep cells were grown in William’s E Medium supplemented with
blasticidin 5 mg/ml, 10% of heat-inactivated fetal calf serum and
100 units/ml of penicillin and streptomycin. The expression was
assessed by Western blot with a Tet repressor antibody (data
not shown). HBV replicating HuH-7 cell lines were obtained as
follows: 2106 of HuH-7 Tet Rep cells were seeded in 100-mm
cell dish and transfected using the calcium phosphate procedure
with 20 mg of an equal mixture of p-HBV(p25) and pI-HA-Precore
or pI-HA-PrecoreWG. Two days post-transfection, cells were
grown in the presence of hygromycin B (0.25 mg/ml, Life technol-
ogies). Medium was changed every two days during one week and
cells were replated to a low conﬂuence. At the end of the selection,
0.5 mg/ml of doxycycline (Clontech) were added during 24 h to
induce HA-Precore or HA-PrecoreWG expression. The CMV indu-
cible promoter containing tetracycline operator sequences allowed
lower expression than a basic CMV promoter, thus preventing cell
toxicity due to a strong expression of Precore. However, we found
out that this “inducible” promoter was extremely leaky, as the
control cells expressed the same level of HA-Precore as doxycy-
cline treated cells. Therefore, we further used this plasmid without
doxycycline induction.
Cytosolic fractionations and total protein extractions
Cytosolic fractionations were performed using a procedure
described previously (Duriez et al., 2008). Forty percent of the
corresponding soluble extract (cytoplasmic) and 10% of the inso-
luble fraction (non-cytoplasmic) were subjected to SDS-PAGE.
Total protein extractions were performed on HEK-293 T cells
48 h after transfection and 24 h after doxycycline addition on
HBV replicating HuH-7 cells. Cells were washed twice with PBS
and suspended in 300 ml of Laemmli buffer (for 107 cells) contain-
ing 100 mM DTT, except when protein dimer formation was
evaluated. Proteins were boiled for 5 min and 10% of the total
protein extract was analyzed by SDS-PAGE.
Immunoprecipitations
Cells were washed twice with PBS and lysed in 1 ml PBS-1%
NP40 buffer containing protease inhibitors purchased from Sigma
(0.5 mM phenylmethanesulfonyl ﬂuoride, 1 mg/ml aprotinin, 1 mg/
ml leupeptin). Lysates were cleared of debris by centrifugation
at 16,000 g for 10 min at 4 1C. For each reaction, 2.5 ml of anti-HA
antibody (Covance Research Products, MMS101R) were coupled
to 50 ml of protein A Sepharose (Sepharose CL-4B, GE Healthcare
17-0780-01) and incubated with cell lysate overnight at 4 1C on a
rotating wheel. Beads were washed with PBS-NP40 1% buffer ﬁve
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times and boiled in Laemmli’s sample buffer. Half of the immu-
noprecipitate and 20% of the crude lysate were subjected to SDS-
PAGE.
Western blot and antibodies
Protein extracts were submitted to electrophoresis on 12.5%
SDS-Polyacrylamide gels and then blotted onto a nitrocellulose
membrane using a semi dry transfer Bio-Rad apparatus following
the manufacturer’s instructions. HBV Precore and Core proteins
were both detected using a polyclonal rabbit anti-Core antibody
(Dako, B0586). Mouse antibodies against BiP (BD Biosciences,
G73320), PDI (Stressgen, SPA891), HA (HA-11, Covance, MMS101R),
Actin (Sigma, A-2066) and gC1qR (Covance Research Products,
MMS-604 R) were used as primary antibodies. A rabbit anti-HBs
antibody directed against the preS2 HBV envelope protein was
kindly provided by Dr Sureau (INTS, Paris). Goat HRP-conjugated
antibodies anti-rabbit (W4011) and anti-mouse (W4021) were
purchased from Promega. Membranes were revealed using the
ECL SuperSignal West Pico kit (Pierce) and exposed to Hyperﬁlm
(GE Healthcare Life Sciences)).
Immunostaining
Cells were seeded on cover slips (Knittelgläser) and transfected.
Forty eight hours after, cells were ﬁxed in a 4% paraformaldehyde-
PBS buffer for 10 min and permeabilized 15 min with 0.5% X100
Triton-PBS buffer. Incubations with antibodies were done during
45 min in 1% BSA-PBS. Primary antibodies rabbit anti-Core (Dako,
B0586), mouse anti-GM130 (BD Biosciences, G65120) and relevant
Alexa Fluor secondary antibodies (Life technologies) were used.
For nuclei detection, cells were stained for 10 min with 2 mg/ml
DAPI (Euromedex). Immunostainings were analyzed with a ﬂuor-
escence Leica DMRHC research microscope with a 631.32 oil
immersion objective.
Puriﬁcation and content analysis of intracellular nucleocapsids.
HBV replicating HuH-7 cells (1107) were lysed in 1 ml of
buffer containing 50 mM Tris–HCl pH 8, 100 mM NaCl, 1 mM
EDTA, 10 mM Mg acetate and 0.7% NP40 during 15 min at 37 1C.
Nuclei and cellular debris were removed by centrifugation (5 min
at 5000 g), and then the supernatant was incubated for 15 min at
37 1C after addition of 200 mg DNase (Sigma, DN-25), 100 mg RNase
(Sigma R48-75) and MgCl2 to a ﬁnal concentration of 6 mM. After
addition of EDTA to a ﬁnal concentration of 15 mM, the lysate was
centrifuged at 18,000 g for 10 min at 4 1C to clarify the extract.
Quantiﬁcation of protein was done using the BCA protein assay
reagent (Pierce). Protein extracts containing intracellular nucleo-
capsids were either analyzed by electrophoresis on native agarose
gel or by SDS-PAGE. For native agarose gel, protein extracts (20 mg)
were loaded on a 1.2% agarose gel. After a 2h30 migration at 50 V,
proteins and nucleocapsids were blotted overnight onto Amer-
sham Hybon™-Nþ membrane (GE Healthcare) with a 10 mM Tris–
HCl pH 7.5, 150 mM NaCl, 1 mM EDTA buffer. The membrane was
incubated in a blocking solution (1X TBS, 0.1% Tween, 10% milk)
and subjected to classical Western blotting analysis. For SDS-PAGE
analysis, nucleocapsids (100 mg of proteins extract) were concen-
trated by centrifugation through a 30% sucrose solution (w/v) in an
SW60 rotor (Beckman Colter) for 2 h at 10 1C at 50,000 rpm. The
pellet fraction was resuspended at 4 1C in 50 ml of PBS and then
50 ml of Laemmli buffer were added. One third of the resuspended
pellet was loaded on SDS polyacrylamide gel and subjected to
Western Blot analysis.
Analysis of extracellular virions
Extracellular medium from HBV HuH-7 cells was recovered and
concentrated on a 10 kDa Amicon Ultracentrifugal ﬁlter. Half of the
residual solution was then loaded onto a 30% sucrose cushion and
processed as described for the intracellular nucleocapsids.
HBe quantiﬁcation in cell media
Extracellular medium from HBV replicating HuH-7 cells
was recovered and HBe quantiﬁcation was done by ELISA assay
(bioMérieux clinical diagnostics).
Structure analysis and display
Coordinates and structure factors were retrieved from the
Protein Data Bank for the HBe dimer (chains E and F in PDB
3V6Z (DiMattia et al., 2013)), the Core dimer in the T¼4 HBV
capsid (chains A and B in PDB 1QGT (Wynne et al., 1999)), and an
assembly-defective Core dimer (mutant Y132A, chains E and F in
PDB 3KXS (Packianathan et al., 2010)). Dimer interfaces were
computed with the software PISA (Krissinel and Henrick, 2007).
Structures were visualized for analysis and rendered for Fig. 1 with
PYMOL (http://www.pymol.org/).
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